The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering
ADHD is a common, chronic neurodevelopmental disorder that often begins in childhood and can persist into adulthood
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
It performs white blood cell differential counts and quantifies red blood cell and platelet morphology,
The funding will accelerate Sinopia’s data-driven drug discovery efforts
The primary goal of the collaboration is joint research into trending and next-generation molecules
Subscribe To Our Newsletter & Stay Updated
